(Q44856596)

6 December 2017

title

Prognostic significance of PDCD4 expression in human salivary adenoid cystic carcinoma (English)

1 reference

6 December 2017

Cheng Qi

1

1 reference

6 December 2017

Yi Shao

2

1 reference

6 December 2017

Ning Li

3

1 reference

6 December 2017

Chunyan Zhang

4

1 reference

6 December 2017

Miaoqing Zhao

5

1 reference

6 December 2017

Fei Gao

6

1 reference

6 December 2017

publication date

7 February 2013

1 reference

6 December 2017

1 reference

6 December 2017

volume

30

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

491

1 reference

Molecular biology of adenoid cystic carcinoma

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Adenoid cystic carcinoma of the parotid gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Adenoid cystic carcinoma of the head and neck--a 20 years experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Management of salivary gland tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

DUG is a novel homologue of translation initiation factor 4G that binds eIF4A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

PDCD4 inhibits the malignant phenotype of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

An essential role of PDCD4 in progression and malignant proliferation of gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Adenoid cystic carcinoma: a retrospective clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Identification of the myb-inducible promoter of the chicken Pdcd4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0491-1

Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma.

21 January 2018

1 reference

12 December 2020

Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients

1 reference

12 December 2020

Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer.

1 reference

12 December 2020

The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma

1 reference

12 December 2020

Clinical significance of programmed cell death 4 expression in malignant progression of human nasal inverted papillomas

1 reference

12 December 2020

Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas

1 reference

12 December 2020

[Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer]

1 reference

12 December 2020

10.1007/S12032-013-0491-1

Identifiers

DOI

1 reference

6 December 2017

1 reference